Learning Objectives:

  1. To review the currently available lipid-lowering therapies.
  2. To understand the Inclusion criteria, methods, and results of ORION 10 and 11 trials that investigated the use of Inclisiran as a lipid lowering therapy.
  3. To critically examine and Identify the strengths and limitation of the trial design for ORION 10 and 11. 


Session date: 
07/29/2022 - 7:30am to 8:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kifah Hussain, MD